99¢ of every dollar received goes to fund cancer research
Advanced Malignancies
Study of Water Soluable Curcumin in Advanced Malignancies
Siqing Fu, MD & Razelle Kurzrock, MD
MD Anderson Cancer Center, Houston, TX
Clinical Title: Phase I Study of Surface-Controlled Water Soluble Curcumin in Patients with Advanced Malignancies
Description: The goal of this clinical research study is to find the highest tolerable doses of surface-controlled water dispersible curcumin that can be given to patients with advanced cancer. The safety of this drug will also be studied.
Clinical Description:
Curcumin is well known for its anticancer activities in cancer cells; however, broad clinical implementation has been limited due to poor oral absorption, rapid metabolism and expeditious systemic elimination. This study tests a novel nanotechnology-enhanced curcumine compound dispersed with colloidal nano-particles, which enhances bioavailability thirty fold.
Status: Active Trial
Accepting Patients? No
NIH Clinical Trial Link: http://www.clinicaltrials.gov/ct2/show/NCT01201694?term=curcumin+and+MD+Anderson&rank=1
DONATE to support Advanced Malignancies Research »
« Back to Funded Clinical Trials
CANCER FACTS:
1,500 American people died today from cancer.
1,500 more will die tomorrow and the next day and the next...
Demanding it all!
Funding innovative cancer research for
Treatments. Cures. Life.